Author:
Kohl Katrin S.,Walop Wikke,Gidudu Jane,Ball Leslie,Halperin Scott,Hammer Sandra Jo,Heath Paul,Varricchio Frederick,Rothstein Edward,Schuind Anne,Hennig Renald
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference27 articles.
1. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults;Casey;Rev Article Drugs,2005
2. Safety and immunogenicity of a pentavalent combination vaccine (diptheria, tetanus, acecullar pertussis, polio, and haemophilus influenzae type b conjugate) when administered as a fourth dose at 15 to 18 months of age;Scheifele;Hum Vaccines,2005
3. Adverse events after immunization with alumimium-containing DPT vaccines: systematic review of the evidence;Jefferson;Lancet,2004
4. An evaluation of the safety and immunogenicity of a five-component acellular pertusssis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae Type b-Tetanus Toxoid conjugate vaccine (PRP-T) in Taiwanese infants;Lee;Pediatrics,1999
5. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four, six months of age;Mills;Vaccine,1998